Bioinvent International Ab

bioinvent international ab is a research-based pharmaceutical company focused on the discovery and development of innovative antibody-based drugs against cancer. the company has unique expertise in antibody drug development from initial concept to late clinical phase. the screening tool, f.i.r.s.t.tm, and the antibody library, n-coder®, are two patented tools that enable identification of relevant human antibodies and disease targets during the discovery phase. bioinvent has also considerable experience in and a facility for process development and production of antibodies for clinical studies. the scope and strength of this platform is also used to develop antibody-based drugs in collaboration with partners who finance the development of the new drug, and provide bioinvent with the right to milestone payments and royalties on sales. these partners include bayer pharma, daiichi sankyo, les laboratoires servier and mitsubishi tanabe pharma.